CONMED Corp

CNMD

CONMED Corp

CNMD

Insider Sentiment (TTM):

Last Purchase:2024-05-13Last Sale:2025-11-21Shares Purchased (TTM):0Shares Sold (TTM):6,355

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:33,223,256Shares Outstanding:31,299,194Institutional Ownership Pct.:106.15%

Earnings Market Reaction:

Filing Date:2026-02-17Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Electromedical & Electrotherapeutic Apparatus

MDT MASI LIVN TMDX ITGR AXGN

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	41	39	34	35	24	38	29	34	24	31	28	26
Accounts Receivable Net Current	248	225	234	221	238	231	239	241	242	230	229	213
Inventory Net	356	364	362	355	347	343	322	322	318	326	327	335
Prepaid Expense And Other Assets Current	29	34	27	28	31	29	33	38	31	39	31	35
Assets Current	673	662	658	639	640	641	624	636	616	626	616	610
Property Plant And Equipment Net	113	112	117	116	116	117	117	118	121	120	117	115
Deferred Income Tax Assets Net	13	-	-	-	11	-	-	-	11	-	-	-
Goodwill	807	807	807	806	805	807	806	806	807	815	816	815
Intangible Assets Net Excluding Goodwill	582	593	602	610	618	626	633	641	649	657	666	674
Other Assets Noncurrent	137	148	145	127	116	125	105	108	96	107	109	106
Assets	2,326	2,322	2,328	2,298	2,306	2,316	2,286	2,309	2,300	2,326	2,323	2,320
Liabilities And Stockhold…
Liabilities Current
Long Term Debt And Capital Lease Obligations Curre…	1	1	1	1	1	1	1	1	1	71	70	70
Accounts Payable Current	94	107	101	96	102	105	101	102	88	82	79	77
Employee Related Liabilities Current	82	76	68	58	65	61	55	50	70	60	55	49
Other Liabilities Current	139	131	125	129	110	116	109	139	152	163	150	125
Liabilities Current	315	315	295	283	278	282	266	291	311	376	353	321
Long Term Debt And Capital Lease Obligations	834	853	881	891	905	940	965	990	973	942	971	995
Deferred Income Tax Liabilities Net	80	75	70	70	74	66	65	64	61	67	66	66
Other Liabilities Noncurrent	64	72	80	76	86	95	107	109	121	144	152	186
Liabilities	1,293	1,314	1,326	1,320	1,344	1,383	1,404	1,455	1,466	1,529	1,543	1,568
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	503	499	494	489	477	471	465	458	447	440	433	420
Retained Earnings Accumulated Deficit	589	572	575	560	560	533	490	466	453	426	416	408
Accumulated Other Comprehensive Income Loss Net Of…	-46	-49	-53	-57	-59	-55	-54	-50	-50	-54	-53	-55
Treasury Stock Common Value	-	-14	-14	-15	-	-16	-19	-20	-	-15	-16	-21
Treasury Stock Value	-13	-	-	-	-16	-	-	-	-15	-	-	-
Stockholders Equity	1,033	1,008	1,003	978	963	933	882	855	834	796	780	752
Liabilities And Stockholders Equity	2,326	2,322	2,328	2,298	2,306	2,316	2,286	2,309	2,300	2,326	2,323	2,320
Allowance For Doubtful Accounts Receivable Current	6	-	-	-	6	-	-	-	6	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	-	-	-	0	-	-	-	0	-	-	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	31	31	31	31	31	31	31	31	31	31	31	31
Treasury Stock Common Shares	0	0	0	0	0	0	0	1	1	1	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	-3.13%	-8.41%	-16.39%	9.11%	-1.86%	-11.32%	-1.79%	-7.71%	-5.84%	-12.39%	-13.65%	-13.61%
2024	20.71%	15.20%	10.71%	10.12%	15.46%	1.86%	9.77%	0.86%	-0.52%	-6.02%	-17.36%	-8.81%
2023	-7.19%	5.98%	5.23%	-11.22%	-8.75%	-20.86%	14.01%	20.13%	18.39%	-4.69%	-8.53%	-5.91%
2022	-	-	-	-	-	-	-	-	-	-4.09%	17.49%	28.03%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Liquidity Ratios
Current Ratio	2.14	2.10	2.23	2.26	2.30	2.27	2.34	2.18	1.98	1.66	1.74	1.90
Quick Ratio	0.92	0.84	0.91	0.91	0.94	0.96	1.01	0.94	0.86	0.69	0.73	0.75
Working Capital	357.82M	347.46M	362.94M	355.85M	361.88M	358.69M	357.42M	344.32M	304.92M	249.33M	262.35M	289.40M
Leverage & Debt
Debt to Equity	1.25	1.30	1.32	1.35	1.40	1.48	1.59	1.70	1.76	1.92	1.98	2.08
Interest Coverage TTM	3.30	3.64	5.04	5.04	5.37	5.22	4.20	3.65	3.03	1.75	1.65	1.77
Debt Ratio	0.56	0.57	0.57	0.57	0.58	0.60	0.61	0.63	0.64	0.66	0.66	0.68
Efficiency & Turnover
Asset Turnover TTM	0.59	0.58	0.57	0.57	0.57	0.56	0.55	0.55	0.54	0.51	0.52	0.54
Days Sales Outstanding TTM	64.46	61.78	65.14	64.15	67.02	65.37	67.00	65.77	63.58	66.76	69.11	65.85
Receivables Turnover TTM	5.66	5.91	5.60	5.69	5.45	5.58	5.45	5.55	5.74	5.47	5.28	5.54
Per Share Metrics
Diluted EPS TTM	-	2.06	3.55	3.81	-	4.23	3.17	2.63	-	1.83	2.78	-3.00
Free Cash Flow Per Share TTM	4.82	4.81	4.79	5.31	4.92	5.38	5.16	4.60	3.40	1.22	0.52	0.22
Dividend Per Share TTM	0.79	0.80	0.80	0.80	0.79	0.80	0.80	0.80	0.78	0.80	0.80	0.79
Margin Metrics
Gross Profit Margin TTM	54.59%	54.22%	56.05%	56.14%	56.08%	55.65%	55.32%	54.92%	54.33%	53.56%	53.51%	53.76%
Operating Profit Margin TTM	7.46%	8.79%	12.99%	13.77%	15.33%	15.37%	12.74%	11.33%	9.69%	5.93%	5.55%	5.49%
Net Profit Margin TTM	3.42%	4.75%	8.31%	9.02%	10.13%	10.23%	7.73%	6.53%	5.18%	4.96%	7.75%	-8.53%
Growth Metrics
Net Revenue Growth (1Y)	5.18%	4.61%	3.94%	4.32%	5.00%	10.23%	12.02%	14.83%	19.06%	9.36%	9.28%	7.68%
Net Income Growth (1Y)	-64.47%	-51.37%	11.77%	44.20%	105.44%	127.25%	11.68%	-187.85%	-179.99%	-170.08%	-177.49%	-238.55%
EPS Growth (1Y)	-64.47%	-51.52%	11.28%	43.30%	105.44%	126.40%	11.13%	-187.08%	-179.99%	-169.47%	-175.25%	-233.63%
Valuation Metrics
P/E TTM	27.01	22.72	14.57	15.63	16.00	16.62	21.31	29.36	52.05	52.25	46.03	-32.92
P/B TTM	1.23	1.44	1.60	1.90	2.20	2.35	2.38	2.83	4.02	3.80	5.21	4.10
P/S TTM	0.92	1.08	1.21	1.41	1.62	1.70	1.65	1.92	2.70	2.59	3.57	2.81
Market Cap	1.27B	1.46B	1.61B	1.86B	2.12B	2.19B	2.10B	2.42B	3.35B	3.03B	4.06B	3.09B
Enterprise Value	2.06B	2.27B	2.45B	2.71B	3.00B	3.09B	3.04B	3.38B	4.30B	4.01B	5.08B	4.12B
Calculated Values
Free Cash Flow TTM	150.88M	148.96M	148.24M	164.55M	153.88M	166.13M	159.08M	141.50M	106.32M	37.50M	15.95M	6.84M
Net Debt	794.13M	814.82M	847.89M	856.67M	881.32M	902.34M	937.02M	956.95M	949.55M	982.29M	1.01B	1.04B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-21Sale

Owner: Glaze, Richard

Title: Chief Information Officer

Shares: 257

Price/Share: $41.21

Value: $10,590.97

Shares Owned: -

Relationship: Officer

Ownership: Direct

2025-11-06Sale

Owner: Garner, Todd W

Title: Executive Vice President & CFO

Shares: 3,500

Price/Share: $43.00

Value: $150,500.00

Shares Owned: 1,836

Relationship: Officer

Ownership: Direct

2025-09-12Sale

Owner: Farkas, Charles

Title: -

Shares: 2,000

Price/Share: $53.52

Value: $107,040.00

Shares Owned: 14,859

Relationship: Director

Ownership: Direct

2025-08-07Sale

Owner: Garner, Todd W

Title: Executive Vice President & CFO

Shares: 598

Price/Share: $52.45

Value: $31,365.10

Shares Owned: -

Relationship: Officer

Ownership: Direct

2025-05-05Sale

Owner: Farkas, Charles

Title: -

Shares: 4,000

Price/Share: $56.94

Value: $227,760.00

Shares Owned: 16,346

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-21	Glaze, Richard	Officer	Chief Information Officer	Direct	Sale	257	41.21	$10,590.97	0	4
2025-11-06	Garner, Todd W	Officer	Executive Vice President & CFO	Direct	Sale	3,500	43.00	$150,500.00	1,836	4
2025-09-12	Farkas, Charles	Director	-	Direct	Sale	2,000	53.52	$107,040.00	14,859	4
2025-08-07	Garner, Todd W	Officer	Executive Vice President & CFO	Direct	Sale	598	52.45	$31,365.10	0	4
2025-05-05	Farkas, Charles	Director	-	Direct	Sale	4,000	56.94	$227,760.00	16,346	4
2025-02-11	Glaze, Richard	Officer	Chief Information Officer	Direct	Sale	257	65.35	$16,794.95	0	4
2024-06-14	Peters, Stanley W Iii	Officer	President AS and AET	Direct	Sale	4,000	71.82	$287,280.00	63	4
2024-05-13	Bronson, David M	Director	-	Direct	Purchase	1,350	72.09	$97,321.50	16,460	4
2024-05-08	Schwarzentraub, Barbara J	Director	-	Indirect	Purchase	1,442	69.26	$99,872.92	1,442	4
2024-05-06	Aronson, Martha Goldberg	Director	-	Indirect	Purchase	2,000	70.98	$141,960.00	2,000	4
2024-04-30	Beyer, Pat	Officer	Chief Operating Officer	Direct	Purchase	3,000	68.30	$204,900.00	10,807	4
2023-12-04	Peters, Stanley W Iii	Officer	President AS and AET	Direct	Sale	2,300	109.93	$252,839.00	63	4
2023-11-07	Peters, Stanley W Iii	Officer	President AS and AET	Direct	Sale	1,200	102.40	$122,880.00	63	4
2023-09-13	Peters, Stanley W Iii	Officer	President AS and AET	Direct	Sale	2,000	107.31	$214,620.00	63	4
2023-08-16	Garner, Todd W	Officer	Executive Vice President & CFO	Direct	Sale	1,355	112.00	$151,760.00	0	4
2023-06-15	Hartman, Curt R	Director,Officer	President, CEO and Chair	Direct	Sale	1,000	136.00	$136,000.00	4,299	4
2023-06-08	Ferrell, John D.	Officer	Executive Vice President - HR	Direct	Sale	1,700	131.81	$224,077.00	702	4
2023-06-08	Peters, Stanley W Iii	Officer	VP GM Advanced Surgery	Direct	Sale	5,000	131.14	$655,700.00	63	4
2023-06-07	Concannon, Brian	Director	-	Direct	Sale	812	129.01	$104,756.12	9,335	4
2023-05-22	Peters, Stanley W Iii	Officer	VP GM Advanced Surgery	Direct	Sale	1,500	120.90	$181,350.00	63	4
2023-05-18	Peters, Stanley W Iii	Officer	VP GM Advanced Surgery	Direct	Sale	1,500	119.24	$178,860.00	63	4
2023-05-01	Concannon, Brian	Director	-	Direct	Sale	2,072	125.00	$259,000.00	9,812	4
2023-04-28	Shagory, Peter K	Officer	EVP, STRAT & CORP DEVT	Direct	Sale	2,442	128.00	$312,576.00	1,861	4
2023-04-28	Pelletier, Johonna Marie	Officer	Treasurer and VP, Tax	Direct	Sale	24,017	126.47	$3,037,429.99	1,317	4
2023-04-28	Berge, Terence M	Officer	VP-Corporate Controller	Direct	Sale	18,700	126.82	$2,371,534.00	1,004	4
2023-04-28	Jonas, Daniel S	Officer	Special Counsel & Corp Secy	Direct	Sale	10,000	126.62	$1,266,200.00	13,462	4
2023-03-14	Hartman, Curt R	Director,Officer	President, CEO and Chair	Direct	Sale	5,000	92.81	$464,050.00	5,299	4
2023-03-13	Garner, Todd W	Officer	Executive Vice President & CFO	Direct	Sale	30,000	90.95	$2,728,500.00	1,115	4
2023-03-02	Jonas, Daniel S	Officer	Special Counsel & Corp Secy	Direct	Sale	10,400	96.16	$1,000,064.00	14,048	4
2022-12-09	Garner, Todd W	Officer	Executive Vice President & CFO	Direct	Sale	4,500	89.31	$401,895.00	1	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

106.15%

Inst. Shares: 33,223,256

Shares Outstanding: 31,299,194

2025-12-31

106.93%

Inst. Shares: 33,099,232

Shares Outstanding: 30,955,000

2025-09-30

108.92%

Inst. Shares: 33,716,394

Shares Outstanding: 30,955,000

2025-06-30

109.84%

Inst. Shares: 33,994,899

Shares Outstanding: 30,949,000

2025-03-31

111.39%

Inst. Shares: 34,501,424

Shares Outstanding: 30,973,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	33,223,256	31,299,194	106.15%
2025-12-31	33,099,232	30,955,000	106.93%
2025-09-30	33,716,394	30,955,000	108.92%
2025-06-30	33,994,899	30,949,000	109.84%
2025-03-31	34,501,424	30,973,000	111.39%
2024-12-31	34,393,326	30,973,000	111.04%
2024-09-30	32,545,359	30,856,000	105.47%
2024-06-30	34,025,795	30,813,000	110.43%
2024-03-31	32,410,056	30,780,000	105.30%
2023-12-31	32,382,796	30,780,000	105.21%
2023-09-30	31,797,961	30,741,000	103.44%
2023-06-30	31,618,855	30,662,000	103.12%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

CONMED Corp (CNMD) — SEC Financial Statements & Analysis

CONMED Corp (CNMD) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. CONMED Corp trades on NYSE as: CNMD. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), CONMED Corp reported a 5.18% year-over-year revenue growth, a Gross Profit Margin of 54.59% (TTM), a Debt-to-Equity ratio of 1.25x, a Price-to-Sales (P/S) ratio of 0.92x (TTM), a Price-to-Book (P/B) ratio of 1.23 (TTM), at a market cap of $1.27B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 5.18%
Gross Profit Margin TTM: 54.59%
Debt To Equity: 1.25x
P/S TTM: 0.92x
P/B TTM: 1.23
Market Cap: $1.27B

Data as of 2025-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CONMED Corp in?

CONMED Corp (CNMD) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is CNMD's market cap?

CONMED Corp (CNMD) has a market capitalization of $1.27B as of 2025-12-31.

What is CNMD's P/E ratio?

CONMED Corp (CNMD)'s trailing twelve month P/E ratio is 27.01x as of 2025-12-31.

What exchange does CNMD trade on?

CONMED Corp (CNMD) trades on the NYSE.

Where is CONMED Corp incorporated?

CONMED Corp is incorporated in DE.

CONMED Corp (CNMD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.